1. Home
  2. NVCR vs TRMK Comparison

NVCR vs TRMK Comparison

Compare NVCR & TRMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • TRMK
  • Stock Information
  • Founded
  • NVCR 2000
  • TRMK 1889
  • Country
  • NVCR Jersey
  • TRMK United States
  • Employees
  • NVCR N/A
  • TRMK N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • TRMK Major Banks
  • Sector
  • NVCR Health Care
  • TRMK Finance
  • Exchange
  • NVCR Nasdaq
  • TRMK Nasdaq
  • Market Cap
  • NVCR 1.8B
  • TRMK 2.2B
  • IPO Year
  • NVCR 2015
  • TRMK 1987
  • Fundamental
  • Price
  • NVCR $17.49
  • TRMK $35.60
  • Analyst Decision
  • NVCR Buy
  • TRMK Hold
  • Analyst Count
  • NVCR 5
  • TRMK 5
  • Target Price
  • NVCR $26.60
  • TRMK $34.60
  • AVG Volume (30 Days)
  • NVCR 1.3M
  • TRMK 220.3K
  • Earning Date
  • NVCR 10-30-2024
  • TRMK 10-22-2024
  • Dividend Yield
  • NVCR N/A
  • TRMK 2.63%
  • EPS Growth
  • NVCR N/A
  • TRMK 111.56
  • EPS
  • NVCR N/A
  • TRMK 3.30
  • Revenue
  • NVCR $549,964,000.00
  • TRMK $555,401,000.00
  • Revenue This Year
  • NVCR $16.23
  • TRMK N/A
  • Revenue Next Year
  • NVCR $6.09
  • TRMK $9.68
  • P/E Ratio
  • NVCR N/A
  • TRMK $10.59
  • Revenue Growth
  • NVCR 8.33
  • TRMK N/A
  • 52 Week Low
  • NVCR $10.87
  • TRMK $19.68
  • 52 Week High
  • NVCR $24.74
  • TRMK $35.75
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 43.24
  • TRMK 67.30
  • Support Level
  • NVCR $15.61
  • TRMK $33.85
  • Resistance Level
  • NVCR $17.31
  • TRMK $35.21
  • Average True Range (ATR)
  • NVCR 1.29
  • TRMK 0.99
  • MACD
  • NVCR 0.05
  • TRMK 0.13
  • Stochastic Oscillator
  • NVCR 11.59
  • TRMK 97.34

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About TRMK Trustmark Corporation

Trustmark Corp is a s a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee and Texas. Its principal products and services include, Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services and others. The company is managed along three operating segments; General Banking, Wealth Management and Insurance. The General Banking segment which generates the majority of the revenue provides all traditional banking products and services, including loans, deposits and also consists of internal operations.

Share on Social Networks: